Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 49.30% is in line with its 5-year average of 47.13%, around the middle of its 5-year range (34.70%–61.17%).
2.50% above its 12-month average of 48.10%.
Reported quarterly gross margin; no daily interpolation. Q1 FY2027 (2026-07-31): 48.48%.
GROSS MARGIN
49.30%
GROSS MARGIN AVG TTM
48.10%
GROSS MARGIN AVG 3Y
45.07%
GROSS MARGIN AVG 5Y
47.13%
GROSS MARGIN AVG 10Y
47.06%
GROSS MARGIN AVG 15Y
43.00%
GROSS MARGIN AVG 20Y
43.50%
CURRENT VS TTM AVG
+2.50%
CURRENT VS 3Y AVG
+9.39%
CURRENT VS 5Y AVG
+4.60%
CURRENT VS 10Y AVG
+4.77%
CURRENT VS 15Y AVG
+14.65%
CURRENT VS 20Y AVG
+13.33%
SECTOR MEDIAN · HEALTHCARE
39.94%
median of 722 covered companies
CURRENT VS SECTOR MEDIAN
+23.44%
vs the sector median at left
Champions Oncology, Inc.
Market Cap
$67.38M
Gross Margin
49.30%
TTM Avg
48.10%
3Y Avg
45.07%
5Y Avg
47.13%
Market Cap
$68.60M
Gross Margin
62.53%
TTM Avg
65.36%
3Y Avg
65.75%
5Y Avg
64.06%
Market Cap
$65.29M
Gross Margin
99.56%
TTM Avg
98.97%
3Y Avg
49.48%
5Y Avg
32.99%
Market Cap
$70.25M
Gross Margin
60.78%
TTM Avg
57.02%
3Y Avg
54.79%
5Y Avg
56.72%
Market Cap
$63.50M
Gross Margin
70.07%
TTM Avg
73.26%
3Y Avg
61.08%
5Y Avg
58.36%
Market Cap
$63.78M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
50.00%
5Y Avg
66.67%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Champions Oncology, Inc. (CSBR) | $67.38M | 49.30% | 48.10% | 45.07% | 47.13% |
| iBio, Inc. (IBIO)vs › | $67.84M | 100.00% | 100.00% | 75.00% | 39.52% |
| RenovoRx, Inc. (RNXT)vs › | $66.68M | 70.88% | 85.44% | 42.72% | 28.48% |
| Fortress Biotech, Inc. (FBIO)vs › | $68.60M | 62.53% | 65.36% | 65.75% | 64.06% |
| Cingulate Inc. (CING)vs › | $66.27M | 0.00% | 0.00% | 0.00% | 0.00% |
| Gossamer Bio, Inc. (GOSS)vs › | $65.29M | 99.56% | 98.97% | 49.48% | 32.99% |
| MindWalk Holdings Corp. (HYFT)vs › | $70.25M | 60.78% | 57.02% | 54.79% | 56.72% |
| Heron Therapeutics, Inc. (HRTX)vs › | $63.50M | 70.07% | 73.26% | 61.08% | 58.36% |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | 0.00% | 0.00% | 50.00% | 66.67% |
| InterCure Ltd. (INCR)vs › | $63.02M | 14.40% | 12.47% | 23.60% | 30.84% |
Gross Margin
49.3%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-07-31 | 48.48% |
| 2026-04-30 | 50.79% |
| 2026-01-31 | 46.65% |
| 2025-10-31 | 51.70% |
| 2025-07-31 | 42.87% |
| 2025-04-30 | 41.15% |
| 2025-01-31 | 61.17% |
| 2024-10-31 | 44.93% |
| 2024-07-31 | 49.70% |
| 2024-04-30 | 48.22% |
| 2024-01-31 | 34.70% |
| 2023-10-31 | 42.82% |
| 2023-07-31 | 38.83% |
| 2023-04-30 | 43.86% |
| 2023-01-31 | 39.72% |
| 2022-10-31 | 47.88% |
| 2022-07-31 | 48.69% |
| 2022-04-30 | 51.69% |
| 2022-01-31 | 51.44% |
| 2021-10-31 | 52.41% |
| 2021-07-31 | 52.05% |
| 2021-04-30 | 46.76% |
| 2021-01-31 | 57.24% |
| 2020-10-31 | 44.21% |
| 2020-07-31 | 44.10% |
| 2020-04-30 | 43.71% |
| 2020-01-31 | 52.01% |
| 2019-10-31 | 49.10% |
| 2019-07-31 | 44.31% |
| 2019-04-30 | 44.27% |
| 2019-01-31 | 46.67% |
| 2018-10-31 | 48.44% |
| 2018-07-31 | 50.47% |
| 2018-04-30 | 42.79% |
| 2018-01-31 | 51.34% |
| 2017-10-31 | 49.01% |
| 2017-07-31 | 47.51% |
| 2017-04-30 | 30.89% |
| 2017-01-31 | 32.51% |
| 2016-10-31 | 50.57% |
| 2016-07-31 | 31.25% |
| 2016-04-30 | 17.45% |
| 2016-01-31 | 17.48% |
| 2015-10-31 | 32.31% |
| 2015-07-31 | 19.45% |
| 2015-04-30 | 31.56% |
| 2015-01-31 | -7.98% |
| 2014-10-31 | 8.66% |
| 2014-07-31 | 9.94% |
| 2014-04-30 | 37.39% |
| 2014-01-31 | 56.04% |
| 2013-10-31 | 39.99% |
| 2013-07-31 | 44.67% |
| 2013-04-30 | 15.42% |
| 2013-01-31 | 57.42% |
| 2012-10-31 | 27.50% |
| 2012-07-31 | 30.15% |
| 2012-04-30 | -10.93% |
| 2012-01-31 | 44.53% |
| 2011-10-31 | 37.91% |
| 2011-07-31 | 44.80% |
| 2011-04-30 | 47.28% |
| 2011-01-31 | 49.63% |
| 2010-10-31 | 40.09% |
| 2010-07-31 | 65.88% |
| 2010-04-30 | 67.89% |
| 2010-01-31 | 50.94% |
| 2009-10-31 | 73.86% |
| 2009-07-31 | 30.56% |
| 2009-04-30 | 83.42% |
| 2009-01-31 | 31.91% |
| 2008-10-31 | 56.08% |
| 2008-07-31 | 61.37% |
| 2008-04-30 | 0.00% |
| 2008-01-31 | 0.00% |
| 2007-10-31 | 0.00% |
| 2007-07-31 | 0.00% |
| 2007-04-30 | 0.00% |
| 2007-01-31 | 0.00% |
| 2006-10-31 | 0.00% |
| 2006-07-31 | 0.00% |
| 2006-04-30 | 0.00% |
| 2006-01-31 | 0.00% |
| 2005-10-31 | 0.00% |
| 2005-07-31 | 0.00% |
| 2005-04-30 | 71.74% |
| 2005-01-31 | 68.77% |
| 2004-10-31 | 67.71% |
| 2004-07-31 | 67.71% |
| 2004-04-30 | 69.58% |
| 2004-01-31 | 67.13% |
| 2003-10-31 | 73.80% |
| 2003-07-31 | 69.33% |
| 2003-04-30 | 73.54% |
| 2003-01-31 | 74.44% |
| 2002-10-31 | 79.30% |
